Recombinant Lactobacillus fermentum tRNA pseudouridine synthase A (truA)

What is tRNA pseudouridine synthase A (truA) and what is its function in bacterial systems?

tRNA pseudouridine synthase A (truA) catalyzes the isomerization of specific uridine residues to pseudouridine (Ψ) in tRNA molecules, primarily at positions 38-40 in the anticodon stem-loop region. This enzyme functions through a complex catalytic mechanism involving a conserved aspartate residue that acts as a nucleophilic catalyst. The reaction begins with the formation of a covalent adduct between this aspartate and the C6 position of the target uridine, facilitating the cleavage of the N-glycosidic bond between uracil and ribose. After bond cleavage, the uracil moiety rotates and forms a new C-C glycosidic bond between its C5 position and the C1' of ribose, resulting in pseudouridine formation .

The pseudouridine modification is critical for proper tRNA folding, stability, and function during protein synthesis, ultimately affecting translational accuracy and efficiency. In Lactobacillus fermentum, truA likely plays similar roles in maintaining proper tRNA function, which is essential for protein synthesis and bacterial adaptation to various environmental conditions.

What methods are available for identifying and characterizing Lactobacillus fermentum in laboratory settings?

Traditional identification of Lactobacillus fermentum relied on culture methods coupled with biochemical tests, which have proven unreliable for precise species identification. Modern molecular approaches offer significantly improved specificity and sensitivity:

• Species-specific PCR: A validated PCR assay using primers derived from variable regions of the 16S rRNA gene (primers LF1: 5'-AATACCGCATTACAACTTTG-3' and LF2: 5'-GGTTAAATACCGTCAACGTA-3') can specifically detect L. fermentum with a sensitivity threshold of approximately 50 bacterial cells .

• 16S rRNA gene sequencing: Full or partial sequencing of the 16S rRNA gene provides definitive identification through phylogenetic analysis.

• MALDI-TOF mass spectrometry: Rapid identification based on protein mass fingerprinting, though reference databases must include appropriate L. fermentum strains.

• Genome sequencing: Whole genome sequencing offers the most comprehensive characterization and can identify strain-specific features relevant to truA research.

When working with recombinant L. fermentum expressing truA, researchers should verify both the bacterial identity and the presence/expression of the recombinant gene through PCR, sequencing, and protein expression analysis to ensure experimental validity .

How does the catalytic mechanism of truA differ from other RNA modification enzymes?

The truA enzyme belongs to the pseudouridine synthase family but exhibits distinct catalytic properties compared to other RNA modification enzymes:

• Unique catalytic mechanism: Unlike many RNA modification enzymes that require cofactors such as SAM (S-adenosylmethionine), truA catalyzes pseudouridylation through an RNA-protein covalent intermediate. A conserved aspartate residue in the enzyme serves as a nucleophilic catalyst, attacking the C6 position of the target uridine to form a covalent adduct, facilitating the isomerization process .

• No cofactor requirements: truA operates without external cofactors, making it energetically efficient compared to methyltransferases and other modification enzymes that consume SAM or ATP.

• Site specificity determinants: While many RNA modification enzymes recognize specific sequence motifs, truA recognizes structural features of the tRNA anticodon loop, particularly positions 38-40, demonstrating structure-based rather than strictly sequence-based recognition.

• Evidence of mechanism: Studies using 5-fluorouracil substituted tRNAs have demonstrated the formation of stable covalent adducts with pseudouridine synthases, supporting the proposed nucleophilic mechanism involving the conserved aspartate residue .

This distinctive catalytic approach makes truA an interesting subject for mechanistic enzymology studies and presents unique opportunities for enzyme engineering applications.

What are the optimal conditions for heterologous expression of recombinant L. fermentum truA?

The optimal expression conditions for recombinant L. fermentum truA must balance protein yield, solubility, and functional activity. Based on established protocols for similar enzymes, researchers should consider:

• Expression system selection:

  • E. coli BL21(DE3) serves as a primary choice for initial expression attempts

  • Rosetta or CodonPlus strains may improve expression if the L. fermentum truA gene contains rare codons

  • Alternative hosts like L. plantarum may provide advantages for proper folding of Lactobacillus proteins, as demonstrated in studies with recombinant L. plantarum expressing fusion proteins

• Vector design considerations:

  • pET-series vectors with T7 promoter systems offer strong, inducible expression

  • N-terminal or C-terminal His6-tags facilitate purification while minimizing interference with enzymatic activity

  • Inclusion of a TEV or PreScission protease site allows tag removal if necessary

• Optimized expression conditions:

  • Induction at lower temperatures (16-20°C) typically improves solubility of recombinant pseudouridine synthases

  • IPTG concentration between 0.1-0.5 mM provides sufficient induction while minimizing stress

  • Extended expression periods (16-20 hours) at lower temperatures often yield better results than short, high-temperature induction

• Media optimization:

  • Rich media (Terrific Broth or 2YT) supplemented with 0.5% glucose can enhance yield

  • Defined mineral media may be beneficial for consistent isotopic labeling if structural studies are planned

These conditions should be systematically tested and refined through small-scale expression trials before scaling up to production levels.

What is the recommended purification protocol for obtaining active recombinant truA enzyme?

A robust purification protocol for recombinant L. fermentum truA should yield pure, active enzyme suitable for biochemical and structural studies:

• Cell lysis and initial extraction:

  • Sonication or French press in buffer containing 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 10% glycerol, 5 mM MgCl₂, 1 mM DTT

  • Inclusion of protease inhibitors (PMSF or commercial cocktail) prevents degradation

  • Clarification by high-speed centrifugation (20,000 × g for 30 minutes)

• Multi-step chromatography strategy:

  • Affinity chromatography: For His-tagged constructs, Ni-NTA with imidazole gradient elution (20-250 mM)

  • Ion exchange chromatography: Typically HiTrap Q or SP columns depending on the theoretical pI of the recombinant truA

  • Size exclusion chromatography: Final polishing step using Superdex 75 or 200 columns to ensure monodispersity

• Activity preservation considerations:

  • Maintain reducing conditions throughout purification (1-5 mM DTT or β-mercaptoethanol)

  • Include divalent cations (typically 5 mM MgCl₂) in all buffers

  • Minimize freeze-thaw cycles; aliquot and flash-freeze final product

• Quality control assessments:

  • SDS-PAGE analysis to verify >95% purity

  • Size exclusion chromatography to confirm monodispersity

  • Mass spectrometry to verify protein identity and integrity

  • Activity assay using model tRNA substrates to confirm functional enzyme

The following table summarizes typical buffer compositions for each purification stage:

This protocol should yield enzyme suitable for detailed biochemical and structural characterization studies .

How can enzyme activity be reliably measured and quantified for recombinant truA?

Reliable measurement of recombinant L. fermentum truA activity requires specialized assays targeting pseudouridine formation:

• Radioactive assays:

  • Tritium release assay: Using [³H]-labeled uridine-containing tRNA substrates, measure released tritium upon pseudouridine formation

  • [¹⁴C]-labeled uridine incorporation assay: Quantify the conversion of radiolabeled uridine to pseudouridine by thin-layer chromatography (TLC) separation

• Chromatographic methods:

  • HPLC analysis: Digest tRNA substrates post-reaction with nucleases and separate nucleosides by HPLC to detect and quantify pseudouridine formation

  • Mass spectrometry detection: LC-MS/MS can identify and quantify pseudouridine with high sensitivity and specificity

• Chemical labeling approaches:

  • CMCT (N-cyclohexyl-N'-(2-morpholinoethyl)carbodiimide) labeling: This chemical specifically reacts with pseudouridine under controlled conditions

  • Primer extension analysis: CMCT-modified pseudouridines cause reverse transcriptase to stop, allowing site-specific detection

• Standardized reaction conditions:

  • Buffer: 50 mM Tris-HCl pH 7.5, 10 mM MgCl₂, 100 mM NH₄Cl, 1 mM DTT

  • Temperature: 37°C (standard) with time-course measurements

  • Substrate concentration: 0.5-2 μM tRNA substrate with 0.1-0.5 μM enzyme

  • Controls: Include heat-inactivated enzyme and catalytically inactive mutant controls

• Kinetic analysis framework:

  • Determine Km and kcat by varying substrate concentration (0.1-10 μM)

  • Analyze pH dependence (pH range 6.0-9.0)

  • Assess temperature optima and thermal stability profiles

For comparative studies, standardized activity units should be defined (e.g., pmol pseudouridine formed per minute per μg enzyme under defined conditions) to enable reliable comparison between different preparations and variants of recombinant truA .

How does the molecular structure of truA determine its substrate specificity?

The substrate specificity of truA is determined by several structural elements that facilitate recognition of specific tRNA features:

Understanding these structural determinants provides opportunities for engineering truA variants with altered specificity or enhanced activity through targeted mutagenesis of key residues involved in substrate recognition and catalysis .

What structural and biochemical evidence supports the current model of truA's catalytic mechanism?

The current model of truA's catalytic mechanism is supported by multiple lines of evidence:

• Structural evidence:

  • Crystal structures of related pseudouridine synthases reveal a conserved catalytic fold with a crucial aspartate positioned to attack the C6 position of uridine

  • Structures of enzyme-RNA complexes show the target uridine flipped out of the RNA helix into the enzyme active site

  • Electron density mapping confirms the proximity of the catalytic aspartate to the C6 position of the target uridine

• Biochemical evidence:

  • Covalent enzyme-RNA adduct formation: Studies with 5-fluorouracil (FUra) substituted tRNAs demonstrate stable covalent adduct formation with pseudouridine synthases

  • The recovered FUra-tRNA after hydrolysis of the adduct shows modification by the addition of water across the 5,6-double bond, forming 5,6-dihydro-6-hydroxy-5-fluorouridine

  • Site-directed mutagenesis of the conserved aspartate abolishes enzymatic activity, confirming its essential role in catalysis

• Mechanistic investigations:

  • Isotope labeling studies confirm the retention of the C1'-C5 bond during the reaction

  • Chemical trapping experiments have identified reaction intermediates consistent with the proposed mechanism

  • The minimal mechanism involves glycosidic bond cleavage, uracil rotation, and C-C bond formation

• Evolutionary conservation:

  • The catalytic mechanism appears conserved across the pseudouridine synthase family

  • Key catalytic residues, particularly the nucleophilic aspartate, are strictly conserved across bacterial species

These multiple lines of evidence collectively support a mechanism where the conserved aspartate acts as a nucleophile, attacking C6 of uridine to form a covalent adduct that facilitates the isomerization process .

How do mutations in key residues affect the catalytic efficiency and substrate specificity of recombinant truA?

Mutations in key residues of truA can have profound effects on both catalytic efficiency and substrate specificity:

• Catalytic core mutations:

  • Mutation of the conserved nucleophilic aspartate (typically to alanine or asparagine) abolishes catalytic activity

  • Mutations of residues coordinating the target uridine can reduce activity without eliminating it completely

  • Alterations to residues involved in acid-base catalysis can significantly impact reaction rates

• Substrate recognition region mutations:

  • Modifications to the positively charged RNA binding groove can alter affinity for tRNA substrates

  • Changes in residues contacting specific positions in the anticodon loop can shift position specificity

  • Mutations that alter the dimensions of the active site pocket may accommodate or exclude different substrates

• Structure-based effects:

  • Distal mutations affecting protein dynamics or conformational changes can have unpredictable effects on activity

  • Alterations in flexible loops can influence substrate binding without directly contacting the RNA

  • Mutations affecting protein stability may indirectly impact catalytic efficiency through altered structural integrity

• Experimental observations from related enzymes:

  • Studies of pseudouridine synthases show that single amino acid substitutions can shift target site preferences

  • Conservative mutations (maintaining similar chemical properties) often preserve activity but may alter kinetic parameters

  • Non-conservative mutations frequently abolish activity but occasionally create novel specificities

The following table summarizes typical effects of mutations in key regions of pseudouridine synthases:

These structure-function relationships provide opportunities for rational engineering of truA variants with novel or enhanced properties through targeted mutagenesis approaches .

How can recombinant L. fermentum expressing truA be used to study the impact of tRNA modifications on bacterial physiology?

Recombinant L. fermentum expressing truA provides a powerful system for investigating the physiological roles of tRNA modifications:

• Controlled expression systems:

  • Design strains with inducible truA expression to modulate pseudouridylation levels

  • Create strains expressing catalytically inactive truA variants as controls

  • Develop complementary strains with truA knockdown/knockout for comparative studies

• Physiological assessment frameworks:

  • Growth curve analysis under various stress conditions (acid, bile, oxidative stress)

  • Antibiotic susceptibility profiles before and after truA induction

  • Translation fidelity measurement using reporter constructs with programmed frameshifts or near-cognate codons

• Molecular phenotyping approaches:

  • Proteome-wide analysis using quantitative proteomics to identify differentially expressed proteins

  • Ribosome profiling to detect changes in translation elongation rates at specific codons

  • tRNA modification mapping using next-generation sequencing approaches

• Stress response characterization:

  • Heat shock response evaluation in modified strains

  • Acid tolerance assessment, particularly relevant for Lactobacillus species

  • Oxidative stress resistance measurements using H₂O₂ challenge assays

• Host interaction studies:

  • Adhesion assays with intestinal epithelial cell lines

  • Immunomodulatory capacity assessment through co-culture with immune cells

  • Competitive exclusion potential against pathogens

This experimental framework allows researchers to systematically investigate how modulation of truA expression and the resulting changes in tRNA modification patterns affect bacterial physiology, stress responses, and potentially probiotic properties of L. fermentum.

What techniques can be used to study the impact of recombinant L. fermentum expressing truA on gut microbiota composition?

Studying the impact of recombinant L. fermentum expressing truA on gut microbiota requires a multi-faceted approach:

• In vivo experimental design:

  • Animal model selection (conventional mice, germ-free mice, or humanized microbiota models)

  • Treatment groups must include: wild-type L. fermentum, recombinant truA-expressing strain, inactive truA mutant strain, and vehicle controls

  • Controlled feeding and housing conditions to minimize confounding variables

• Microbiome analysis methods:

  • 16S rRNA gene amplicon sequencing for taxonomic profiling

  • Shotgun metagenomics for functional gene analysis

  • Species-specific qPCR for targeted quantification of key bacterial taxa

  • RNA-Seq (metatranscriptomics) to assess functional activity changes

• Diversity metrics and statistical approaches:

  • Alpha diversity measurements (Shannon-Wiener index) to assess species richness within samples

  • Beta diversity analysis to compare community structures between treatment groups

  • Statistical methods like PERMANOVA to assess significance of community shifts

• Functional assessments:

  • Metabolomics analysis of fecal samples

  • Short-chain fatty acid quantification

  • Bile acid profiling

  • Metaproteomics for functional protein expression

• Host response measurements:

  • Immune cell populations in gut-associated lymphoid tissue

  • Cytokine profiles in intestinal tissue

  • Serum antibody levels (IgG, IgA)

  • Intestinal barrier integrity assessment

How does recombinant L. fermentum truA influence bacterial adaptation to environmental stressors?

Recombinant L. fermentum expressing modified levels of truA can significantly impact stress adaptation through several mechanisms:

• Translation-mediated stress responses:

  • Pseudouridylation in tRNA influences decoding efficiency and accuracy

  • This can alter the expression of stress response proteins through translational control

  • Under stress conditions, modified tRNAs may maintain translation of key protective proteins

• Experimental approaches to assess stress adaptation:

  • Comparative growth analysis under multiple stressors (acid, bile, oxidative, osmotic)

  • Survival rate determination after acute lethal stress exposure

  • Competition assays between wild-type and recombinant strains under stress conditions

• Molecular mechanisms of enhanced stress resistance:

  • Proteome remodeling: Quantitative proteomics before and after stress exposure

  • Changes in protein synthesis rates: Pulse-labeling experiments with radioactive amino acids

  • Alterations in translation fidelity: Reporter systems measuring mistranslation rates

• Cross-protection phenomena:

  • Pre-adaptation experiments to determine if truA overexpression confers cross-protection against multiple stressors

  • Characterization of the transcriptional and translational responses using RNA-Seq and Ribo-Seq

  • Evaluation of energy conservation strategies under stress conditions

• Practical applications in probiotics:

  • Stability testing under simulated gastrointestinal conditions

  • Shelf-life assessment in different storage formulations

  • Acid and bile resistance evaluation relevant for probiotic applications

This research framework provides comprehensive insights into how modulating truA expression can influence stress adaptation in L. fermentum, with potential applications for developing more robust probiotic strains with enhanced survival in the gastrointestinal tract.

What computational approaches can predict novel substrates or functions for recombinant L. fermentum truA?

Advanced computational methods offer powerful approaches for predicting novel substrates and functions for recombinant L. fermentum truA:

• Structure-based prediction methods:

  • Homology modeling of L. fermentum truA based on crystal structures of related pseudouridine synthases

  • Molecular docking simulations with various RNA structures to identify potential novel substrates

  • Molecular dynamics simulations to capture enzyme flexibility and substrate adaptation

  • Structure-based virtual screening of RNA libraries to identify non-tRNA substrates

• Sequence-based prediction approaches:

  • Phylogenetic analysis to identify evolutionary relationships and potential functional divergence

  • Machine learning models trained on known pseudouridylation sites to predict novel targets

  • Motif discovery algorithms to identify sequence or structural patterns in potential substrates

  • Coevolutionary analysis to identify RNA partners that have evolved alongside truA

• Systems biology integration:

  • Network analysis of genes co-regulated with truA to identify functional relationships

  • Metabolic modeling to predict phenotypic impacts of altered truA activity

  • Integration of transcriptomics and proteomics data to identify systems affected by truA

• Predictive models of substrate recognition:

  • Position-specific scoring matrices for nucleotides surrounding known modification sites

  • Support vector machines or neural networks trained on known targets to identify common features

  • RNA secondary structure prediction combined with accessibility analysis

• Experimental validation strategies:

  • High-throughput screening of predicted substrates using in vitro modification assays

  • CRISPR-Cas9 editing of predicted target sites to assess phenotypic impacts

  • RNA immunoprecipitation to identify RNAs bound by truA in vivo

These computational approaches can significantly accelerate the discovery of novel truA functions and substrates, especially when combined with strategic experimental validation of key predictions.

How can recombinant L. fermentum truA be engineered for enhanced activity or altered specificity?

Engineering recombinant L. fermentum truA for novel properties requires sophisticated protein engineering approaches:

• Structure-guided rational design:

  • Site-directed mutagenesis of residues in the RNA binding pocket to alter substrate specificity

  • Introduction of additional electrostatic interactions to enhance binding affinity

  • Modification of the active site environment to improve catalytic efficiency

  • Engineering based on structural insights from pseudouridine synthase mechanisms, particularly focusing on the conserved aspartate and surrounding residues that influence reactivity

• Directed evolution strategies:

  • Error-prone PCR to generate libraries of truA variants

  • Selection systems coupling pseudouridylation to cell survival

  • High-throughput screening approaches using fluorescent or colorimetric readouts

  • Iterative rounds of selection with increasing stringency

• Domain swapping and chimeric enzymes:

  • Exchange of substrate recognition domains between truA and other pseudouridine synthases

  • Creation of fusion proteins with alternative RNA binding domains

  • Integration of orthogonal regulatory domains for controlled activity

• Computational design approaches:

  • In silico screening of virtual mutant libraries

  • Molecular dynamics simulations to predict stability and activity of variants

  • Machine learning-guided optimization based on experimental data

• Specific engineering targets:

  • Temperature stability improvements for industrial applications

  • pH tolerance expansion for gastrointestinal survival

  • Altered substrate specificity to target non-native RNAs

  • Increased catalytic efficiency through optimization of rate-limiting steps

• Performance validation framework:

  • Comparative kinetic analysis of wild-type and engineered variants

  • Structural characterization to confirm predicted modifications

  • In vivo functionality assessment in relevant biological contexts

These engineering approaches can create truA variants with novel properties suitable for biotechnological applications or research tools for RNA modification studies.

What are the potential applications of recombinant L. fermentum expressing truA in synthetic biology and therapeutic development?

Recombinant L. fermentum expressing truA offers diverse applications in both synthetic biology and therapeutic development:

• Synthetic biology applications:

  • RNA-based regulatory circuit design utilizing controlled pseudouridylation

  • Development of engineered probiotics with enhanced stress resistance

  • Creation of biosensors where truA activity is coupled to detectable outputs

  • Synthetic RNA devices with pseudouridine-dependent folding or function

• Therapeutic development opportunities:

  • Enhanced probiotic strains with improved gastrointestinal survival

  • Immunomodulatory probiotics leveraging the demonstrated ability of recombinant Lactobacillus to modulate immune responses, including IgG and IgA production and CD4+ T cell populations

  • Live bacterial delivery vehicles for vaccine antigens or therapeutic proteins

  • Microbiome engineering tools for targeted modulation of gut ecology

• Delivery systems for therapeutic applications:

  • Oral formulations with enhanced acid resistance

  • Targeted delivery to specific gastrointestinal regions

  • Controlled release systems responding to specific environmental triggers

  • Biofilm-based persistent delivery platforms

• Immunomodulatory applications:

  • Design of strains targeting specific immune pathways

  • Development of adjuvants for oral vaccines

  • Modulation of gut immune responses in inflammatory conditions

  • Enhancement of barrier function in intestinal epithelium

• Industrial biotechnology applications:

  • RNA modification tools for commercial RNA production

  • Enhanced protein expression systems utilizing optimized tRNA modifications

  • Biocatalysts with improved stability for industrial processes

  • Diagnostic tools based on RNA modification detection

These applications leverage the unique properties of L. fermentum as a potential probiotic organism combined with the RNA modification capabilities of recombinant truA, creating opportunities for innovation across multiple fields of biotechnology and medicine .